ArticleFrontiers in neurology2020

The Use of Vitamin K2 in Patients With Parkinson's Disease and Mitochondrial Dysfunction (PD-K2): A Theranostic Pilot Study in a Placebo-Controlled Parallel Group Design.

Jannik Prasuhn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.